Avita Medical Inc (AVH) - Total Liabilities
Based on the latest financial reports, Avita Medical Inc (AVH) has total liabilities worth AU$70.39 Million AUD (≈ $49.81 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Avita Medical Inc (AVH) cash conversion ratio to assess how effectively this company generates cash.
Avita Medical Inc - Total Liabilities Trend (1994–2025)
This chart illustrates how Avita Medical Inc's total liabilities have evolved over time, based on quarterly financial data. Check AVH cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Avita Medical Inc Competitors by Total Liabilities
The table below lists competitors of Avita Medical Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Decidr Ai Industries Ltd
AU:DAI
|
Australia | AU$14.88 Million |
|
Hsin Kao Gas Co Ltd
TW:9931
|
Taiwan | NT$3.28 Billion |
|
Li Peng Enterprise Co Ltd
TW:1447
|
Taiwan | NT$9.18 Billion |
|
Kross Ltd
NSE:KROSS
|
India | Rs1.47 Billion |
|
De Licacy Industrial Co Ltd
TW:1464
|
Taiwan | NT$11.72 Billion |
|
Samil Pharm
KO:000520
|
Korea | ₩226.31 Billion |
|
Dala Energi AB
ST:DE
|
Sweden | Skr125.74 Million |
Liability Composition Analysis (1994–2025)
This chart breaks down Avita Medical Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Avita Medical Inc stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.67 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.17 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -10.56 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.73 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Avita Medical Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Avita Medical Inc (1994–2025)
The table below shows the annual total liabilities of Avita Medical Inc from 1994 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | AU$75.21 Million ≈ $53.22 Million |
+20.18% |
| 2024-06-30 | AU$62.58 Million ≈ $44.28 Million |
+215.04% |
| 2023-06-30 | AU$19.87 Million ≈ $14.06 Million |
+57.82% |
| 2022-06-30 | AU$12.59 Million ≈ $8.91 Million |
+25.11% |
| 2021-06-30 | AU$10.06 Million ≈ $7.12 Million |
-30.99% |
| 2020-06-30 | AU$14.58 Million ≈ $10.32 Million |
+199.57% |
| 2019-06-30 | AU$4.87 Million ≈ $3.44 Million |
+64.90% |
| 2018-06-30 | AU$2.95 Million ≈ $2.09 Million |
+15.91% |
| 2017-06-30 | AU$2.55 Million ≈ $1.80 Million |
+45.46% |
| 2016-06-30 | AU$1.75 Million ≈ $1.24 Million |
+42.74% |
| 2015-06-30 | AU$1.23 Million ≈ $867.67K |
-31.35% |
| 2014-06-30 | AU$1.79 Million ≈ $1.26 Million |
-27.19% |
| 2013-06-30 | AU$2.45 Million ≈ $1.74 Million |
+14.00% |
| 2012-06-30 | AU$2.15 Million ≈ $1.52 Million |
+26.54% |
| 2011-06-30 | AU$1.70 Million ≈ $1.20 Million |
-56.17% |
| 2010-06-30 | AU$3.88 Million ≈ $2.75 Million |
+287.84% |
| 2009-06-30 | AU$1.00 Million ≈ $707.85K |
-60.72% |
| 2008-06-30 | AU$2.55 Million ≈ $1.80 Million |
+138.67% |
| 2007-06-30 | AU$1.07 Million ≈ $755.11K |
-44.69% |
| 2006-06-30 | AU$1.93 Million ≈ $1.37 Million |
+5.72% |
| 2005-06-30 | AU$1.82 Million ≈ $1.29 Million |
+256.95% |
| 2004-06-30 | AU$511.27K ≈ $361.76K |
-41.90% |
| 2003-12-31 | AU$880.00K ≈ $622.66K |
+180.76% |
| 2003-06-30 | AU$313.44K ≈ $221.78K |
-43.93% |
| 2002-12-31 | AU$559.00K ≈ $395.53K |
+6.36% |
| 2002-06-30 | AU$525.57K ≈ $371.88K |
+1351.65% |
| 2001-06-30 | AU$36.21K ≈ $25.62K |
-58.71% |
| 2000-06-30 | AU$87.69K ≈ $62.05K |
+342.35% |
| 1999-06-30 | AU$19.82K ≈ $14.03K |
+4.35% |
| 1998-06-30 | AU$19.00K ≈ $13.44K |
-61.80% |
| 1997-06-30 | AU$49.74K ≈ $35.19K |
-41.90% |
| 1996-06-30 | AU$85.60K ≈ $60.57K |
-64.52% |
| 1995-06-30 | AU$241.24K ≈ $170.70K |
-36.85% |
| 1994-06-30 | AU$381.99K ≈ $270.29K |
-- |
About Avita Medical Inc
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitili… Read more